{
 "url": "https://etfiq.com/funds/pill/holdings/",
 "section": "funds",
 "title": "PILL Holdings: All 66 Positions (Oct 22, 2026) | ETFIQ",
 "description": "PILL holdings as of Oct 22, 2026: swaps on SPSIPH worth 230.8% of net assets, and the cash behind them. Every line, with its source and date.",
 "as_of": "Oct 22, 2026",
 "ticker": "PILL",
 "fund": "Direxion Daily Pharmaceutical & Medical Bull 3X ETF",
 "fund_page": "https://etfiq.com/funds/pill",
 "positions": 66,
 "positions_listed_on_page": 66,
 "lead": "PILL held swaps on SPSIPH worth 230.8% of its net assets on Oct 22, 2026. With the 69.2% it holds directly, its exposure is 300.0%.",
 "source": {
  "name": "Direxion",
  "url": "https://www.direxion.com/product/daily-pharmaceutical-medical-bull-3x-etf",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-22",
  "file_date": "2026-10-23"
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "SPSIPH swap asset leg",
   "ticker": "SPSIPH",
   "weight_pct": 109.651,
   "page": null
  },
  {
   "rank": 2,
   "holding": "SPSIPH swap asset leg",
   "ticker": "SPSIPH",
   "weight_pct": 56.968,
   "page": null
  },
  {
   "rank": 3,
   "holding": "SPSIPH swap asset leg",
   "ticker": "SPSIPH",
   "weight_pct": 54.826,
   "page": null
  },
  {
   "rank": 4,
   "holding": "SPSIPH swap asset leg",
   "ticker": "SPSIPH",
   "weight_pct": 9.316,
   "page": null
  },
  {
   "rank": 5,
   "holding": "Xeris Biopharma Holdings Inc",
   "ticker": null,
   "weight_pct": 1.962,
   "page": null
  },
  {
   "rank": 6,
   "holding": "Veradermics Inc",
   "ticker": null,
   "weight_pct": 1.936,
   "page": null
  },
  {
   "rank": 7,
   "holding": "Pacira Biosciences Inc",
   "ticker": null,
   "weight_pct": 1.764,
   "page": null
  },
  {
   "rank": 8,
   "holding": "Amneal Pharmaceuticals Inc",
   "ticker": null,
   "weight_pct": 1.654,
   "page": null
  },
  {
   "rank": 9,
   "holding": "ELI Lilly & Co",
   "ticker": null,
   "weight_pct": 1.613,
   "page": null
  },
  {
   "rank": 10,
   "holding": "Maze Therapeutics Inc",
   "ticker": null,
   "weight_pct": 1.611,
   "page": null
  },
  {
   "rank": 11,
   "holding": "Perrigo Co PLC",
   "ticker": null,
   "weight_pct": 1.59,
   "page": null
  },
  {
   "rank": 12,
   "holding": "Viatris Inc",
   "ticker": null,
   "weight_pct": 1.56,
   "page": null
  },
  {
   "rank": 13,
   "holding": "Zoetis Inc",
   "ticker": null,
   "weight_pct": 1.558,
   "page": null
  },
  {
   "rank": 14,
   "holding": "Pfizer Inc",
   "ticker": null,
   "weight_pct": 1.525,
   "page": null
  },
  {
   "rank": 15,
   "holding": "Ligand Pharmaceuticals",
   "ticker": null,
   "weight_pct": 1.488,
   "page": null
  },
  {
   "rank": 16,
   "holding": "Royalty Pharma PLC- Cl A",
   "ticker": null,
   "weight_pct": 1.465,
   "page": null
  },
  {
   "rank": 17,
   "holding": "ANI Pharmaceuticals Inc",
   "ticker": null,
   "weight_pct": 1.453,
   "page": null
  },
  {
   "rank": 18,
   "holding": "Indivior Pharmaceuticals Inc",
   "ticker": null,
   "weight_pct": 1.415,
   "page": null
  },
  {
   "rank": 19,
   "holding": "Prestige Consumer Healthcare",
   "ticker": null,
   "weight_pct": 1.415,
   "page": null
  },
  {
   "rank": 20,
   "holding": "Septerna Inc",
   "ticker": null,
   "weight_pct": 1.402,
   "page": null
  },
  {
   "rank": 21,
   "holding": "Organon & Co",
   "ticker": null,
   "weight_pct": 1.401,
   "page": null
  },
  {
   "rank": 22,
   "holding": "Johnson & Johnson",
   "ticker": null,
   "weight_pct": 1.394,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Supernus Pharmaceuticals Inc",
   "ticker": null,
   "weight_pct": 1.393,
   "page": null
  },
  {
   "rank": 24,
   "holding": "Merck & Co. Inc.",
   "ticker": null,
   "weight_pct": 1.389,
   "page": null
  },
  {
   "rank": 25,
   "holding": "Innoviva Inc",
   "ticker": null,
   "weight_pct": 1.388,
   "page": null
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Goldman Finl Sq Trsry Inst 506",
   "weight_pct": 19.242
  },
  {
   "holding": "Dreyfus Govt Cash Man Ins",
   "weight_pct": 5.643
  },
  {
   "holding": "Goldman Sachs Fin Gov 465 Institut",
   "weight_pct": 5.126
  }
 ],
 "weights": "share of net assets, as the source states them; a swap line’s weight is the exposure it gives",
 "csv": "https://etfiq.com/funds/pill/holdings/pill-holdings.csv",
 "json_book": "https://etfiq.com/funds/pill/holdings/index.json",
 "markdown": "https://etfiq.com/funds/pill/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of PILL, data as of Oct 22, 2026. https://etfiq.com/funds/pill/holdings/",
 "exposure_pct": {
  "swaps": 230.8,
  "futures": 0,
  "held_directly": 69.2,
  "together": 300.0,
  "daily_target": 3.0,
  "swaps_track": [
   "SPSIPH"
  ]
 }
}
